D. Western Therapeutics Institute, Inc. (TYO:4576)

TYO:4576 Revenue

D. Western Therapeutics Institute had revenue of 15.00M JPY in the quarter ending March 31, 2026, a decrease of -84.50%. This brings the company's revenue in the last twelve months to 305.24M, down -34.15% year-over-year. In the year 2025, D. Western Therapeutics Institute had annual revenue of 387.00M, down -17.83%.

• Revenue (ttm): 305.24M
• Revenue Growth: -34.15%
• P/S Ratio: 13.63
• Revenue / Employee: 16.07M
• Employees: 19
• Market Cap: 4.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	387.00M	-84.00M	-17.83%
Dec 31, 2024	471.00M	43.00M	10.05%
Dec 31, 2023	428.00M	-20.00M	-4.46%
Dec 31, 2022	448.00M	34.00M	8.21%
Dec 31, 2021	414.00M	59.00M	16.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error